Scully Calls Reimbursement Squeeze-Play On Prices; CMS/FDA MoU Imminent
This article was originally published in The Gray Sheet
Executive Summary
CMS is curbing device prices by setting reimbursement levels for new technology at slightly lower rates than the prices charged by manufacturers, according to Administrator Tom Scully
You may also be interested in...
Imaging, Cardiac Care Linked To Rising Healthcare Costs – BlueCross Study
Escalating MRI use does not reduce total utilization of CT scans and other imaging modalities, suggesting that increased availability is associated with uptake of other imaging services, according to a Health Affairs study
Imaging, Cardiac Care Linked To Rising Healthcare Costs – BlueCross Study
Escalating MRI use does not reduce total utilization of CT scans and other imaging modalities, suggesting that increased availability is associated with uptake of other imaging services, according to a Health Affairs study
Mammography QA Standards Contemplated By JAMA Study Authors
The value of mandatory hospital quality measures, long championed by CMS Administrator Tom Scully, is supported by a study comparing U.S. mammography screening practices with those in the UK